Eli Lilly, Boehringer Ingelheim’s Jardiance turns up heat on AstraZeneca’s Farxiga with broad EU heart failure approval

Eli Lilly, Boehringer Ingelheim’s Jardiance turns up heat on AstraZeneca’s Farxiga with broad EU heart failure approval
fkansteiner
Mon, 03/07/2022 – 08:50